GeneDx Holdings Corp. (WGS)

GeneDx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	202.57	234.69	212.2	179.32	196.17
Revenue Growth (YoY)	-13.69%	10.60%	18.33%	-8.59%	47.12%
Cost of Revenue	112.56	261.44	228.8	175.3	113.39
Gross Profit	90.01	-26.75	-16.6	4.03	82.79
Selling, General & Admin	194.71	338.24	318.73	163.93	68.84
Research & Development	58.27	86.2	105.16	72.7	34.91
Other Operating Expenses	17.63	216.46	5.66	9.4	9.45
Operating Expenses	270.6	640.9	429.55	246.02	113.2
Operating Income	-180.6	-667.65	-446.15	-241.99	-30.41
Interest Expense / Income	-1.11	0.67	2.84	2.47	0.78
Other Expense / Income	-2.79	-70.29	-203.59	-3.13	-1.49
Pretax Income	-176.69	-598.03	-245.39	-241.34	-29.7
Income Tax	-0.93	-49.05	0	0	0
Net Income	-175.77	-548.98	-245.39	-241.34	-29.7
Preferred Dividends	0	0	0	0	3.04
Net Income Common	-175.77	-548.98	-245.39	-241.34	-32.74
Shares Outstanding (Basic)	24	10	3	0	0
Shares Outstanding (Diluted)	24	10	3	0	0
Shares Change	137.49%	212.57%	2112850.97%	3775.00%	-99.99%
EPS (Basic)	-7.23	-53.63	-74.91	-1552188.00	-8713848.00
EPS (Diluted)	-7.23	-53.63	-74.91	-1552188.00	-8713848.00
Free Cash Flow	-181.82	-333.48	-211.22	-125.1	-34.18
Free Cash Flow Per Share	-7.48	-32.58	-64.49	-804592.08	-9096327.83
Gross Margin	44.43%	-11.40%	-7.82%	2.25%	42.20%
Operating Margin	-89.15%	-284.48%	-210.25%	-134.95%	-15.50%
Profit Margin	-86.77%	-233.91%	-115.64%	-134.58%	-16.69%
Free Cash Flow Margin	-89.76%	-142.09%	-99.54%	-69.76%	-17.43%
EBITDA	-144.07	-538.06	-219.19	-224.73	-22.69
EBITDA Margin	-71.12%	-229.26%	-103.30%	-125.32%	-11.57%
Depreciation & Amortization	33.73	59.31	23.36	14.13	6.23
EBIT	-177.81	-597.37	-242.56	-238.87	-28.92
EBIT Margin	-87.78%	-254.53%	-114.31%	-133.21%	-14.74%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).